SKB410 for Injection in Solid Tumors

Summary

This is a multicenter, open-label, multiple-dose dose finding and expansion study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and anti-tumor efficacy of SKB410 for injection in patients with advanced solid tumors.

Timeline

Start

2023-07-06

Primary completion

2026-12-30

Completion

2026-12-30

Drugs

Indications